National Program Provides Diagnosis and Treatment Discussion List

The Cancer Support Community created a discussion tips list so patients can better ask questions about diagnosis and treatments:

"Having a solid patient/physician relationship may seem like a luxury, but for those who are being treated for diseases like lymphoma, it's a necessity. Many people living with cancer are unsure how to work with their health care team to do this.

Effective communication is a critical part of cancer care, but a survey conducted online by Harris Interactive (R) on behalf of Cephalon consisting of 133 patients diagnosed with indolent non-Hodgkin lymphoma (NHL) and 150 hematologist/oncologists, reveals crucial communication gaps and misconceptions that can affect the quantity, quality and types of information doctors and patients share during limited appointment times. Further, a quarter of the surveyed patients (25 percent) said they don't remember their questions when seeing the doctor and more than three-quarters of them (79 percent) wanted guidance on how to communicate more effectively with their physicians. "

Read More: http://www.abc6onyourside.com/sections/lifestyle/health/11927

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap